Position in QGEN
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$2,619
+$1,178 QoQ
Shares Held
67
+86.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#295
of 332 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Cromwell Holdings LLC holds $1,775,903 across 17 Diagnostics & Research names. QGEN ranks #16 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
1,078 | $540,465 | |
| 2 | DHR |
Danaher Corp /De/
|
2,189 | $416,960 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
277 | $145,823 | |
| 4 | A |
Agilent Technologies, Inc.
|
1,024 | $136,017 | |
| 5 | WAT |
Waters Corp /De/
|
299 | $112,136 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
571 | $110,328 | |
| 7 | DGX |
Quest Diagnostics Inc
|
389 | $82,448 | |
| 8 | LH |
Labcorp Holdings Inc.
|
242 | $67,760 |
All Filings in QGEN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,619 | 67 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $1,441 | 36 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,708 | 38 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $51,291 | 1,148 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $55,172 | 1,148 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $44,566 | 1,110 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $50,853 | 1,142 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $52,040 | 1,142 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $46,924 | 1,142 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||